• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 24 G X 0.56 IN. BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 24 G X 0.56 IN. BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 381411
Device Problem Insufficient Information (3190)
Patient Problem Staphylococcus Aureus (2058)
Event Date 01/14/2019
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that an infant developed (b)(6) at the iv sit from where a 24 g x 0.56 in.Bd insyte-n¿ autoguard¿ shielded iv catheter was removed."baby developed (b)(6) in iv site 24 hours after removal.".
 
Manufacturer Narrative
Investigation summary: dhr - the lot number was built on afa line 4 from 25jun2017 thru 27jun2017.Packaged on packaging line 11 on 01jul2017.Review of dhr revealed all required challenge samples, set-up and in process testing was performed in accordance with the quality plans.The finish product testing results items passed per specifications.No quality notification were initiated during the build of this lot number.Received a 24ga unit within a sealed package from lot: 7170679.All contents within were intact.Visual examination: no damage was observed on areas the package received.The seal of the package was acceptable per specifications and sterility was not compromised.Water-leak test: the water leak was performed on the received package, no leakage was observed on any area.Indeterminate: the returned unit did not display any adverse characteristics that would contribute to the defect the customer experienced, and the failure described in the event description could not be replicated at the laboratory.
 
Event Description
It was reported that an infant developed mrsa at the iv sit from where a 24 g x 0.56 in.Bd insyte-n¿ autoguard¿ shielded iv catheter was removed."baby developed mrsa in iv site 24 hours after removal.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
24 G X 0.56 IN. BD INSYTE-N¿ AUTOGUARD¿ SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key8324404
MDR Text Key135677350
Report Number1710034-2019-00163
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier30382903814115
UDI-Public30382903814115
Combination Product (y/n)N
PMA/PMN Number
K952861
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other,use
Type of Report Initial,Followup
Report Date 03/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Expiration Date05/31/2020
Device Catalogue Number381411
Device Lot Number7170679
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/22/2019
Initial Date Manufacturer Received 01/17/2019
Initial Date FDA Received02/08/2019
Supplement Dates Manufacturer Received01/17/2019
Supplement Dates FDA Received03/07/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-